Physician profile
Robert Andrew Keller
NPI 1962794503
$48,133.06
in general payments reported to CMS, 2019-2025
12 companies · $20K in 2025
The $20K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,120 · 2020: $6,201 · 2021: $1,365 · 2022: $350 · 2023: $6,232 · 2024: $7,772 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Travel and Lodging: $1,593 · Food and Beverage: $1,413 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,025.00 |
| Travel and Lodging | $1,592.68 |
| Food and Beverage | $1,412.76 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $33,607.97 | 2021-2025 | Alphavent, Omega, Nanotack Flex |
| Arthrex, INC. | $10,056.26 | 2019-2025 | |
| Pinnacle, INC | $3,183.53 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $888.38 | 2019-2025 | Comprehensive Shoulder System, Tapestry, Oxford Partial Knee |
| Djo, LLC | $181.65 | 2019-2023 | Donjoy, Aircast |
| Piedmont Plus Innovation | $110.53 | 2023 | |
| Boston Scientific Corporation | $20.61 | 2023 | |
| Bioventus LLC | $19.28 | 2020 | |
| Smith+Nephew, INC. | $19.18 | 2019 | |
| Fidia Pharma USA INC. | $15.95 | 2019 | |
| Ossur Americas, INC. | $14.92 | 2025 | Unloader One X |
| Vericel Corporation | $14.80 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.